• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硝普钠加腹膜透析与标准血液透析的比较。

Comparison of sodium nitroprusside added peritoneal dialysis and standard haemodialysis.

作者信息

Nand N, Mahajan S K, Wig N, Sharma M, Aggarwal H K, Seth R K

机构信息

Dept of Medicine, Pt. B.D.S., Postgraduate Institute of Medical Sciences Rohtak.

出版信息

J Assoc Physicians India. 1996 Nov;44(11):780-3.

PMID:9251452
Abstract

Thirty patients of acute or acute on chronic renal failure (ACRF) were randomly divided into two group of 15 cases each. Group A patients received 36 cycles of intermittent peritoneal dialysis (PD) with an exchange volume of one litre and duration of one hour per cycle. The 36 cycles of PD were divided into 12 clearance periods of 3 cycles each. Sodium Nitroprusside (SNP) was added in a dose of 4 mg/litre of dialysate in alternate clearance periods. Group B patients were given 4 hours of haemodialysis (HD) to compare the efficacy of two modes of dialysis. Symptomatic relief was observed in various uraemic signs and symptoms like vomiting, level of consciousness, fluid overload, hiccough and asterexis in most of the patients in both the groups. The percentage fall in blood urea and serum creatinine was 57.02 Vs 58.04 mg% and 46.9 Vs 47.8 mg% in group A and B respectively (P 70.5 each). Total dialysate urea removal following PD and HD was 118.8 +/- 57.3 gm and 98.5 +/- 37.0 gm respectively and also there was no significant difference in total creatinine removal. No untoward effects were observed with PD. However, following HD, 5 patients developed hypotension, supraventricular tachycardia was observed in one and disequilibrium syndrome in 8 of them. Therefore, it can be concluded that SNP added PD is comparable to 4 hours of haemodialysis both clinically as well as biochemically and in situations where facilities for HD do not exist or it is contraindicated, PD may be preferred mode of therapy.

摘要

30例急性或慢性肾衰竭急性加重(ACRF)患者被随机分为两组,每组15例。A组患者接受36个周期的间歇性腹膜透析(PD),每次交换量为1升,每个周期持续1小时。这36个周期的PD被分为12个清除期,每个清除期3个周期。在交替的清除期,每升透析液中加入4毫克硝普钠(SNP)。B组患者接受4小时的血液透析(HD),以比较两种透析方式的疗效。两组大多数患者的各种尿毒症体征和症状,如呕吐、意识水平、液体超负荷、呃逆和扑翼样震颤等均有症状缓解。A组和B组血尿素和血清肌酐的下降百分比分别为57.02对58.04毫克%和46.9对47.8毫克%(每组P>0.5)。PD和HD后透析液总尿素清除量分别为118.8±57.3克和98.5±37.0克,肌酐总清除量也无显著差异。PD未观察到不良反应。然而,HD后,5例患者出现低血压,1例出现室上性心动过速,8例出现失衡综合征。因此,可以得出结论,添加SNP的PD在临床和生化方面与4小时血液透析相当,在不存在HD设备或HD禁忌的情况下,PD可能是首选的治疗方式。

相似文献

1
Comparison of sodium nitroprusside added peritoneal dialysis and standard haemodialysis.硝普钠加腹膜透析与标准血液透析的比较。
J Assoc Physicians India. 1996 Nov;44(11):780-3.
2
Effect of intraperitoneal administration of sodium nitroprusside on the efficacy of peritoneal dialysis.腹腔注射硝普钠对腹膜透析疗效的影响
J Assoc Physicians India. 1995 Mar;43(3):173-5.
3
An analysis of the effectiveness and benefits of peritoneal dialysis and haemodialysis using Nigerian made PD fluids.使用尼日利亚产腹膜透析液对腹膜透析和血液透析的有效性及益处进行的分析。
Afr J Med Med Sci. 2005 Sep;34(3):227-33.
4
Effect of vasodilator and surface active drugs on the efficacy of peritoneal dialysis.血管扩张剂和表面活性药物对腹膜透析疗效的影响。
J Assoc Physicians India. 1992 Apr;40(4):233-6.
5
Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.接受腹膜透析和血液透析的成年尿毒症患者的生长激素、胰岛素样生长因子-I及其结合蛋白(IGFBP-1和-3)
Clin Endocrinol (Oxf). 2004 Jun;60(6):741-9. doi: 10.1111/j.1365-2265.2004.02049.x.
6
High membrane transport status on peritoneal dialysis is not associated with reduced survival following transfer to haemodialysis.腹膜透析时的高膜转运状态与转为血液透析后的生存降低无关。
Nephrol Dial Transplant. 2007 Oct;22(10):3005-12. doi: 10.1093/ndt/gfm324. Epub 2007 Jun 2.
7
Evaluation of dialysis dose during combination therapy with peritoneal dialysis and hemodialysis.腹膜透析与血液透析联合治疗期间透析剂量的评估。
Adv Perit Dial. 2007;23:135-9.
8
Evaluation of efficacy of standard haemodialysis and verapamil added peritoneal dialysis.标准血液透析与加用维拉帕米的腹膜透析疗效评估。
Indian J Med Sci. 1997 Mar;51(3):75-81.
9
Comparison of peritoneal dialysis and haemodialysis after renal transplant failure.肾移植失败后腹膜透析与血液透析的比较。
Nephrol Dial Transplant. 2006 Jun;21(6):1669-74. doi: 10.1093/ndt/gfl010. Epub 2006 Feb 9.
10
Therapy outcome in peritoneal dialysis patients transferred from haemodialysis.从血液透析转为腹膜透析患者的治疗结果
Nephrol Dial Transplant. 2009 Sep;24(9):2889-94. doi: 10.1093/ndt/gfp132. Epub 2009 Apr 2.

引用本文的文献

1
Interventions for preventing haemodialysis dysequilibrium syndrome.预防血液透析失衡综合征的干预措施。
Cochrane Database Syst Rev. 2024 May 22;5(5):CD015526. doi: 10.1002/14651858.CD015526.pub2.
2
Peritoneal dialysis for acute kidney injury.急性肾损伤的腹膜透析
Cochrane Database Syst Rev. 2017 Dec 4;12(12):CD011457. doi: 10.1002/14651858.CD011457.pub2.